PubRank

D H Katz

Author PubWeight™ 271.39‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The regulatory influence of activated T cells on B cell responses to antigen. Adv Immunol 1972 9.43
2 Cell interactions between histoincompatible T and B lymphocytes. II. Failure of physiologic cooperative interactions between T and B lymphocytes from allogeneic donor strains in humoral response to hapten-protein conjugates. J Exp Med 1973 9.32
3 Cell interactions between histoincompatible T and B lymphocytes. VII. Cooperative responses between lymphocytes are controlled by genes in the I region of the H-2 complex. J Exp Med 1975 7.64
4 Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization. J Immunol 1980 6.69
5 The function and interrelationships of T-cell receptors, Ir genes and other histocompatibility gene products. Transplant Rev 1975 5.88
6 Carrier function in anti-hapten immune responses. I. Enhancement of primary and secondary anti-hapten antibody responses by carrier preimmunization. J Exp Med 1970 5.71
7 Critical role of determinant presentation in the induction of specific responses in immunocompetent lymphocytes. J Exp Med 1973 5.30
8 The allogeneic effect on immune responses: model for regulatory influences of T lymphocytes on the immune system. Transplant Rev 1972 5.23
9 New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugates. Biochemistry 1979 5.02
10 The allogeneic effect in inbred mice. II. Establishment of the cellular interactions required for enhancement of antibody production by the graft-versus-host reaction. J Exp Med 1972 4.70
11 Carrier function in anti-hapten antibody responses. 3. Stimulation of antibody synthesis and facilitation of hapten-specific secondary antibody responses by graft-versus-host reactions. J Exp Med 1971 4.29
12 Cell interactions between histoincompatible T and B lymphocytes. The H-2 gene complex determines successful physiologic lymphocyte interactions. Proc Natl Acad Sci U S A 1973 4.12
13 Cell interactions between histoincompatible T and B lymphocytes. IV. Involvement of the immune response (Ir) gene in the control of lymphocyte interactions in responses controlled by the gene. J Exp Med 1973 4.05
14 Activation of T and B lymphocytes in vitro. II. Biological and biochemical properties of an allogeneic effect factor (AEF) active in triggering specific B lymphocytes. J Exp Med 1974 3.54
15 Carrier function in anti-hapten antibody responses. IV. Experimental conditions for the induction of hapten-specific tolerance or for the stimulation of anti-hapten anamnestic responses by "nonimmunogenic" hapten-polypeptide conjugates. J Exp Med 1971 3.30
16 Activation of T and B lymphocytes in vitro. III. Presence of Ia determinants on allogeneic effect factor. J Exp Med 1974 3.29
17 Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2. J Exp Med 1981 3.27
18 Activation of T and B lymphocytes in vitro. I. Regulatory influence of bacterial lipopolysaccharide (LPS) on specific T-cell helper function. J Exp Med 1974 2.90
19 The histocompatibility-linked immune response genes. Adv Cancer Res 1975 2.64
20 Macrophage-activating factor produced by a T cell hybridoma: physiochemical and biosynthetic resemblance to gamma-interferon. J Immunol 1983 2.61
21 Carrier function in anti-hapten immune responses. II. Specific properties of carrier cells capable of enhancing anti-hapten antibody responses. J Exp Med 1970 2.54
22 Cell interactions between histoincompatible T and B lymphocytes. I. Allogeneic effect by irradiated host T cells on adoptively transferred histoincompatible B lymphocytes. J Exp Med 1973 2.49
23 Radioresistance of carrier-specific helper thymus-derived lymphocytes in mice. Proc Natl Acad Sci U S A 1972 2.35
24 Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial. J Am Acad Dermatol 2001 2.12
25 Radioresistance of cooperative function of carrier-specific lymphocytes in antihapten antibody responses. Science 1970 2.03
26 Cell interactions between histoincompatible T and B lymphocytes. VI. Cooperative responses between lymphocytes derived from mouse donor strains differing at genes in the S and D regions of the H-2 complex. J Exp Med 1974 1.99
27 The allogeneic effect in inbred mice. I. Experimental conditions for the enhancement of hapten-specific secondary antibody responses by the graft-versus-host reaction. J Exp Med 1972 1.99
28 Hapten-specific IgE antibody responses in mice. I. Secondary IgE responses in irradiated recipients of syngeneic primed spleen cells. J Exp Med 1973 1.87
29 Immunological tolerance in bone marrow-derived lymphocytes. I. Evidence for an intracellular mechanism of inactivation of hapten-specific precursors of antibody-forming cells. J Exp Med 1972 1.86
30 The allergic phenotype: manifestation of 'allergic breakthrough' and imbalance in normal 'damping' of IgE antibody production. Immunol Rev 1978 1.83
31 Adaptive differentiation of murine lymphocytes. I. Both T and B lymphocytes differentiating in F1 transplanted to parental chimeras manifest preferential cooperative activity for partner lymphocytes derived from the same parental type corresponding to the chimeric host. J Exp Med 1978 1.83
32 Identification of a T cell hybridoma that produces large quantities of macrophage-activating factor. J Exp Med 1982 1.81
33 Secretion of leukotriene C and other arachidonic acid metabolites by macrophages challenged with immunoglobulin E immune complexes. J Exp Med 1982 1.73
34 Macrophage activation: priming activity from a T-cell hybridoma is attributable to interferon-gamma. Proc Natl Acad Sci U S A 1983 1.73
35 Carrier function in anti-hapten antibody responses. V. Analysis of cellular events in the enhancement of antibody responses by the "allogeneic effect" in DNP-OVA-primed guinea pigs challenged with a heterologous DNP-conjugate. J Immunol 1971 1.63
36 Cellular site of action of various adjuvants in antibody responses to hapten-carrier conjugates. J Immunol 1973 1.62
37 Hapten-specific IgE antibody responses in mice. IV. Evidence for distinctive sensitivities of IgE and IgG B lymphocytes to the regulatory influence of T cells. J Immunol 1974 1.57
38 Hapten-specific IgE antibody responses in mice. II. Cooperative interactions between adoptively transferred T and B lymphocytes in the development of IgE response. J Exp Med 1973 1.55
39 Control of t-lymphocyte and B-lymphocyte activation by two complementing Ir-GLphi immune response genes. J Exp Med 1976 1.52
40 Cell interactions between histoincompatible T and B lymphocytes. V. Failure of histoincompatible T cells to interfere with physiologic cooperation between syngeneic T and B lymphocytes. J Immunol 1974 1.51
41 Induction of B cell tolerance in vitro to 2,4-dinitrophenyl coupled to a copolymer of D-glutamic acid and D-lysine (DNP-D-GL). J Exp Med 1973 1.45
42 Patterns of immune reactivity in autoimmune murine strains. I. Cell-mediated immune responses induced by H-2 indentical and H-2 incompatible stimulator cells. J Immunol 1979 1.43
43 Ferritin, a Hodgkin's disease associated antigen. Proc Natl Acad Sci U S A 1974 1.43
44 Resistance of guinea pigs to leukemia following transfer of immunocompetent allogeneic lymphoid cells. Cancer Res 1972 1.42
45 The role of the histocompatibilty gene complex in lymphocyte defferetiation. Cold Spring Harb Symp Quant Biol 1977 1.41
46 Hapten-specific IgE antibody responses in mice. VII. Conversion of IgE "non-responder" strains to IgE "responders" by elimination of suppressor T cell activity. J Immunol 1977 1.40
47 Cell interactions between histoincompatible T and B lymphocytes. VIII. In vivo cooperative responses between lymphocytes are controlled by genes in the K-end of the H-2 complex. J Immunol 1975 1.40
48 Genetic control of immune responses in vitro. IV. Conditions for cooperative interactions between nonresponder parental B cells and primed (responder plus nonresponder) F1 T cells in the development of an antibody response under Ir gene control in vitro. J Exp Med 1974 1.40
49 Antigen-specific immunocompetency, B cell function, and regulatory helper and suppressor T cell activities in spontaneously autoimmune mice. J Immunol 1979 1.39
50 Hapten-specific IgE antibody responses in mice. VI. Selective enhancement of IgE antibody production by low doses of X-irradiation and by cyclophosphamide. J Immunol 1976 1.36
51 The allogeneic effect in inbred mice. 3. Unique antigenic structural requirements in the expression of the phenomenon on unprimed cell populations in vivo. J Exp Med 1973 1.35
52 Induction of T-lymphocyte responses to a small molecular weight antigen. III. T-T cell interactions to determinants linked together: suppression vs. enhancement. J Exp Med 1975 1.32
53 Hapten-specific tolerance. Preferential depression of the high affinity antibody response. J Exp Med 1972 1.31
54 Mechanisms involved in the antileukemic effect of immunocompetent allogeneic lymphoid cell transfer. Cancer Res 1972 1.30
55 Human IgE antibody synthesis in vitro: stimulation of IgE responses by pokeweed mitogen and selective inhibition of such responses by human suppressive factor of allergy (SFA). J Immunol 1981 1.29
56 The immune capacity of lymphocytes after cross-linking of surface immunoglobulin receptors by antibody. J Immunol 1972 1.28
57 Recent studies on the regulation of IgE antibody synthesis in experimental animals and man. Immunology 1980 1.28
58 Augmented anti-S 3 antibody responses to an S 3 -protein conjugate. J Immunol 1971 1.27
59 Suppression of hapten-specific delayed-type hypersensitivity responses in mice by idiotype-specific suppressor T cells after administration of anti-idiotypic antibodies. J Exp Med 1979 1.26
60 Carrier function in anti-hapten antibody responses. VI. Establishment of experimental conditions for either inhibitory or enhancing influences of carrier-specific cells on antibody production. J Immunol 1973 1.21
61 Failure to induce tolerance to 2,4-dinitrochlorobenzene contact sensitivity with a 2,4-dinitrophenyl (DNP) conjugate of a copolymer of D-glutamic acid and D-lysine, a specific tolerogen for DNP B cells. J Immunol 1974 1.20
62 A clonal analysis of the IgE response and its implications with regard to isotope commitment. J Exp Med 1981 1.18
63 Immunological tolerance in bone marrow-derived lymphocytes. 3. Tolerance induction in primed B cells by hapten conjugates of unrelated immunogenic or "nonimmunogenic" carriers. J Exp Med 1974 1.17
64 Antigenic differences between natural and recombinant murine IL-1. Lymphokine Res 1988 1.16
65 Collagen-induced arthritis in mice. Relationship of collagen-specific and total IgE synthesis to disease. J Immunol 1991 1.15
66 The allogeneic effect in inbred mice. IV. Regulatory influences of graft-vs.-host reactions on host T lymphocyte functions. J Exp Med 1973 1.15
67 Construction of T cell hybridomas secreting allogeneic effect factor. J Exp Med 1980 1.11
68 Nephritogenic properties of cross-reacting kidney-fixing antibodies to heart, spleen and muscle. J Immunol 1967 1.11
69 IL-10 stimulates murine antigen-driven antibody responses in vitro by regulating helper cell subset participation. Cell Immunol 1996 1.10
70 Potentiation of helper T cell function in IgE antibody responses by bacterial lipolysaccharide (LPS). J Immunol 1974 1.09
71 Cell interactions between histoincompatible T an B lymphocytes. IX. The failure of histoincompatible cells is not due to suppression and cannot be circumvented by carrier-priming T cells with allogeneic macrophages. J Immunol 1976 1.09
72 Activation of T and B lymphocytes in vitro. VI. Biochemical and physicochemical characterization of the allogeneic effect factor. J Immunol 1977 1.09
73 Regulation of IgE antibody production by serum molecules. I. Serum from complete Freund's adjuvant-immune donors suppresses irradiation-enhanced IgE production in low responder mouse strains. J Immunol 1978 1.06
74 IgE antibody responses in vitro: from rodents to man. Prog Allergy 1982 1.06
75 Adaptive differentiation of murine lymphocytes. II. The thymic microenvironment does not restrict the cooperative partner cell preference of helper T cells differentiating in F1 leads to F1 thymic chimeras. J Exp Med 1979 1.06
76 Hapten-specific IgE antibody responses in mice. 3. Establishment of parameters for generation of helper T cell function regulating the primary and secondary responses of IgE and IgG B lymphocytes. J Immunol 1974 1.05
77 Comparison of laboratory test use among three urgent care clinics. R I Med J 1990 1.04
78 Induction of immunological tolerance in bone marrow-derived lymphocytes of the IgE antibody class. Proc Natl Acad Sci U S A 1973 1.03
79 Stimulation of primary in vitro IgE antibody responses in culture of human peripheral mononuclear cells. J Exp Med 1981 1.02
80 The role of histocompatibility gene products in lymphocyte triggering and differentiation. Fed Proc 1976 1.01
81 Induction of T-lymphocyte responses to a small molecular weight antigen. II. specific tolerance induced in azebenzenearsonate (ABA)-specific T cells in Guniea pigs by administration of low doses of an ABA conjugate of chloroacetyl tyrosine in incomplete Freund's adjuvant. J Exp Med 1975 1.00
82 Control of IgE antibody production by suppressor substances. J Allergy Clin Immunol 1978 1.00
83 Immunological tolerance in bone marrow-derived lymphocytes. II. Effects of allogeneic cell interactions and enzymatic digestion with trypsin or inactivated hapten-specific precursors of antibody-forming cells. J Exp Med 1974 1.00
84 Regulation of IgE antibody production by serum molecules. IV. Complete Freund's adjuvant induces both enhancing and suppressive activities detectable in the serum of low and high responder mice. J Immunol 1979 1.00
85 Activation of T and B lymphocytes in vitro: presence of beta2-microblobulin determinants on allogeneic effect factor. Proc Natl Acad Sci U S A 1975 0.99
86 Introduction of intravascular coagulation and focal tissue necrosis in rats by administration of anti-connective tissue antibodies. Am J Pathol 1968 0.99
87 The IgE antibody system is coordinately regulated by FcR epsilon-positive lymphoid cells and IgE-selective soluble factors. Int Arch Allergy Appl Immunol 1985 0.99
88 Production and isolation of helper and suppressor factors. J Immunol Methods 1980 0.98
89 Adaptive differentiation of lymphocytes: theoretical implications for mechanisms of cell--cell recognition and regulation of immune responses. Adv Immunol 1980 0.98
90 IgE class-restricted tolerance induced by neonatal administration of soluble or cell-bound IgE. J Exp Med 1983 0.97
91 The binding of IgE to murine Fc epsilon RII is calcium-dependent but not inhibited by carbohydrate. J Immunol 1990 0.97
92 Constitutive and mitogen-induced production of T cell growth factor by stable T cell hybridoma lines. J Immunol 1982 0.97
93 Hapten specific IgE antibody responses in mice. V. Differential resistance of IgE and IgG B lymphocytes to X-irradiation. J Immunol 1976 0.96
94 Immunoglobulin E-rheumatoid factor in the serum of patients with rheumatoid arthritis, asthma, and other diseases. J Clin Invest 1981 0.96
95 Failure of lymphocytes to reexpress antigen receptors after brief interaction with a tolerogenic D-amino acid copolymer. Proc Natl Acad Sci U S A 1974 0.94
96 Immunogenicity of macrophage-bound antigens: the requirement for hapten and carrier determinants to be on the same molecule for T and B lymphocyte collaboration. Eur J Immunol 1973 0.94
97 Activation of T and B lymphocytes in vitro. V. Cellular locus, metabolism and genetics of induction, and production of the allogeneic effect factor. J Immunol 1977 0.94
98 Immature B cells as the target for in vivo tolerance induction. J Immunol 1981 0.93
99 The biology of monoclonal lymphokines secreted by T cell lines and hybridomas. Adv Immunol 1982 0.93
100 FcR epsilon+ lymphocytes and regulation of the IgE antibody system. I. A new class of molecules, termed IgE-induced regulants (EIR), which modulate FcR epsilon expression by lymphocytes. J Immunol 1984 0.93
101 Induction of autoantibodies to thyroglobulin by anti-idiotypic antibodies. J Immunol 1984 0.93
102 Purification of Hodgkin's disease tumor-associated antigens. Proc Natl Acad Sci U S A 1973 0.93
103 Mechanism of adjuvant activity of poly A:U on antibody responses to hapten-carrier conjugates. Cell Immunol 1973 0.93
104 Specificities of NZB anti-H-2d CML reactions: role of Qa-1 and retroviral gp70 antigens. J Immunol 1981 0.92
105 Activation of T and B lymphocytes in vitro. IV. Regulatory influence on specific T cell functions by a thymus extract factor. J Immunol 1975 0.92
106 Cloning and nucleotide sequence of mouse immunoglobulin epsilon chain cDNA. Proc Natl Acad Sci U S A 1982 0.91
107 IgE immune complexes stimulate arachidonic acid release by mouse peritoneal macrophages. Proc Natl Acad Sci U S A 1982 0.91
108 Induction of tolerance to nucleic acid determinants by administration of a complex of nucleoside D-glutamic acid and D-lysine (D-GL). J Immunol 1975 0.90
109 Induction if immunological tolerance to the major antigenic determinant of penicillin: a therapeutic approach to penicillin allergy. Proc Natl Acad Sci U S A 1976 0.90
110 Antigen-induced deoxyribonucleic acid synthesis in mouse lymphocytes. II. Analysis of the cell populations required for and responding to antigen stimulation in vitro. J Immunol 1973 0.90
111 Haplotype preference in lymphocyte differentiation. I. Development of haplotype-specific helper and suppressor activities in F1 hybrid-activated T cell populations. J Immunol 1977 0.90
112 Murine lymphocytes expressing Fc receptors for IgE (FcR epsilon). I. Conditions for inducing FcR epsilon + lymphocytes and inhibition of the inductive events by suppressive factor of allergy (SFA). J Immunol 1981 0.89
113 Regulation of IgE antibody production by serum molecules. VII. The IgE-selective damping activity of suppressive factor of allergy (SFA) is exerted across both strain and species restriction barriers. J Immunol 1980 0.89
114 Regulation of IgE antibody production by serum molecules. II. Strain-specificity of the suppressive activity of serum from complete freund's adjuvant-immune low responder mouse donors. J Immunol 1978 0.89
115 The anti-herpes simplex virus activity of n-docosanol includes inhibition of the viral entry process. Antiviral Res 1998 0.88
116 FcR epsilon+ lymphocytes and regulation of the IgE antibody system. IV. Delineation of target cells and mechanisms of action of SFA and EFA in inhibiting in vitro induction of FcR epsilon expression. J Immunol 1984 0.87
117 Regulation of the IgE system: experimental and clinical aspects. Allergy 1984 0.87
118 The allogeneic effect on tumor growth. I. Inhibition of a murine plasmacytoma, MOPC 315, by the graft-vs-host reaction. J Immunol 1977 0.87
119 Regulation of IgE antibody production by serum molecules. III. Induction of suppressive activity by allogeneic lymphoid cell interactions and suppression of IgE synthesis by the allogeneic effect. J Exp Med 1979 0.87
120 Characterization of an immune response gene in mice controlling IgE and IgM antibody responses to ragweed pollen extract and its 2,4-dinitrophenylated derivative. Eur J Immunol 1974 0.86
121 Inuction of immunological tolerance in immunoglobulin E B lymphocytes in rats. J Allergy Clin Immunol 1975 0.85
122 Antigen concentration determines helper T cell subset participation in IgE antibody responses. Cell Immunol 1992 0.85
123 Heavy and light chains of a mouse monoclonal autoantibody express the same idiotype. J Immunol 1985 0.85
124 New concepts concerning the clinical control of IgE synthesis. Clin Allergy 1979 0.85
125 Analysis of the promoter elements necessary for IL-4 and anti-CD40 antibody induction of murine Fc epsilon RII (CD23): comparison with the germline epsilon promoter. J Immunol 1997 0.85
126 Stimulation of tumor-specific cytotoxic T-lymphocyte responses in vitro by hapten-reactive helper T lymphocytes and the allogeneic effect. Clin Immunol Immunopathol 1980 0.84
127 Existence of T cells manifesting self-reactivity indistinguishable from alloreactivity. J Immunol 1980 0.84
128 IgE-mediated chemotaxis of rat basophilic leukemia cells towards specific antigen. J Exp Med 1983 0.84
129 IgE-antigen complexes enhance Fc epsilon R and Ia expression by murine B lymphocytes. J Exp Med 1988 0.84
130 Orchestration of partner cell preferences of cooperating T and B lymphocytes derived from primed conventional F1 mice. J Immunol 1980 0.84
131 IgE class-restricted tolerance induced by neonatal administration of soluble or cell-bound IgE. Cellular mechanisms. J Exp Med 1984 0.84
132 Complete genomic sequence of the murine low affinity Fc receptor for IgE. Demonstration of alternative transcripts and conserved sequence elements. J Immunol 1991 0.84
133 Antigen-induced deoxyribonucleic acid synthesis in mouse lymphocytes. I. The nature and specificity of lymphocyte activation by hemocyanin and dinitrophenyl carrier conjugates. J Immunol 1973 0.84
134 FcR epsilon+ lymphocytes and regulation of the IgE antibody system. V. Preliminary physicochemical characterization of the T cell-selective IgE-induced regulant EIRT. J Immunol 1986 0.84
135 Regulation of the murine Fc epsilon RII (CD23) gene. Functional characterization of an IL-4 enhancer element. J Immunol 1994 0.83
136 "Allergic breakthrough" after antigen sensitization: height of IgE synthesis is temporally related to diurnal variation in endogenous steroid production. J Immunol 1980 0.83
137 Regulation of IgE antibody production by serum molecules. V. Evidence that coincidental sensitization and imbalance in the normal damping mechanism results in "allergic breakthrough". J Immunol 1979 0.83
138 Induction of immunologic tolerance to the trimellitate haptenic group in mice: model for a therapeutic approach to trimellitic anhydride-induced hypersensitivity syndromes in humans? J Allergy Clin Immunol 1980 0.83
139 Hapten-specific tolerance induced by hapten conjugates of D-glutamic acid, D-lysine (D-Gl) or isologous gamma-globulin: evidence for central B cell tolerance in the presence of carrier-primed helper T cells. J Immunol 1978 0.83
140 Biology and chemistry of low affinity IgE receptor (Fc epsilon RII/CD23). Crit Rev Immunol 1991 0.83
141 Lymphocytes in Peyer's patches of the mouse: analysis of the constituent cells in terms of their capacities to mediate functions of mature T and B lymphocytes. J Immunol 1973 0.83
142 n-Docosanol inhibits in vitro replication of HIV and other retroviruses. AIDS Res Hum Retroviruses 1996 0.82
143 The role of the histocompatibility gene complex in lymphocyte differentiation. Transplant Proc 1976 0.82
144 Human IgE synthesis in vitro by pokeweed mitogen-stimulated human lymphoid cells: verification with a reconfirmed epsilon-specific radioimmunoassay. J Immunol 1984 0.82
145 The induction of autoreactive T lymphocytes by allogeneic effect factor (AEF): relevance to normal pathways of lymphocyte differentiation. Immunol Rev 1980 0.82
146 Regulatory mechanisms in the immune response. Soc Gen Physiol Ser 1974 0.82
147 A rapid screening assay for detection of IgE-binding factors in humans. J Immunol Methods 1983 0.82
148 FcR epsilon+ lymphocytes and regulation of the IgE antibody system. II. FcR epsilon+ B lymphocytes initiate a cascade of cellular and molecular interactions that control FcR epsilon expression and IgE production. J Immunol 1984 0.82
149 Regulation of IgE antibody production by serum molecules. VI: Preliminary biochemical and immunological characterization of serum molecules active in suppressing IgE antibody production. Immunopharmacology 1979 0.81
150 Adaptive differentiation of murine lymphocytes. III. T and B lymphocytes display reciprocal preference for one another to develop optimal interacting partner cell sets. J Immunol 1979 0.81
151 Induction of a ragweed-specific allergic state in Ir-gene-restricted nonresponder mice. J Exp Med 1977 0.80
152 Specificity of anti-nucleoside antibodies in systemic lupus erythematosus. Clin Immunol Immunopathol 1983 0.80
153 Immunological tolerance to allergenic protein determinants: a therapeutic approach for selective inhibition of IgE antibody production. Proc Natl Acad Sci U S A 1979 0.80
154 The major influence on helper T cell cooperative partner cell preferences is exerted by the extrathymic environment. J Immunol 1980 0.80
155 Biological effects of anti-idiotypic antibodies on lymphocyte function. I. Analysis of the effects on B lymphocytes of combining site and framework-directed anti-T-15 idiotypic antibodies. Cell Immunol 1980 0.80
156 Anti-herpes simplex virus activity of n-docosanol correlates with intracellular metabolic conversion of the drug. J Lipid Res 1996 0.80
157 B lymphocyte regulation of the immune system. I. In vivo biologic activity of the novel lymphokine, B cell-derived enhancing factor (BEF). J Immunol 1985 0.79
158 Manipulation of cytotoxic T lymphocyte responses to syngeneic tumors. I. Hapten-reactive helper T lymphocytes augment tumor-specific CTL responses in vitro. J Immunol 1979 0.79
159 Production of antigen-nonspecific immunoregulatory lymphokines by T cell hybridomas. Curr Top Microbiol Immunol 1982 0.79
160 The biologic effects of allogeneic effect factor on T lymphocytes. I. The mitogenic activity and the autonomous induction of cytotoxic T lymphocytes by AEF. J Immunol 1980 0.78
161 The antiviral drug docosanol as a treatment for Kaposi's sarcoma lesions in HIV type 1-infected patients: a pilot clinical study. AIDS Res Hum Retroviruses 2001 0.78
162 Self-recognition as a means of cell communication in biologic systems: the immune system is not an exception to the general rule. Birth Defects Orig Artic Ser 1978 0.78
163 Immunologic alterations related to expression of the allergic phenotype. J Allergy Clin Immunol 1986 0.78
164 Adaptive differentiation of murine lymphocytes: implications for mechanisms of cell--cell recognition and the regulation of immune responses. Fed Proc 1979 0.78
165 The biological effects of allogeneic effect factor (AEF) on T lymphocytes. III.--Interferon does not contribute to the biological activities displayed by AEF on both T and B lymphocytes. Ann Immunol (Paris) 1980 0.78
166 Biphasic effect of kallikrein on IgE and IgG1 syntheses by LPS/IL-4-stimulated B cells. Cell Immunol 1993 0.78
167 The cellular lesion responsible for exaggerated IgE synthesis accompanying allergic breakthrough. Cell Immunol 1989 0.78
168 The biologic effects of allogeneic factor on T lymphocytes. II. The specificity of AEF-induced cytotoxic T lymphocytes. J Immunol 1980 0.78
169 Fc receptors for IgE (Fc epsilon R) on human lymphoid cells: inducible expression of Fc epsilon RII (CD23) on lymphocytes and detection by monoclonal anti-Fc epsilon RII antibody. Cell Immunol 1989 0.77
170 Biological effects of allogeneic effect factor on T lymphocytes: in vitro induction of cytotoxic T lymphocytes manifesting preferential lytic activity against H-2-identical tumor cells. Proc Natl Acad Sci U S A 1979 0.77
171 Mouse monoclonal IgE antibodies specific for ragweed pollen antigens. Hybridoma 1984 0.77
172 Differentiation of murine bone marrow stem cells in vitro: long-term growth promoted by a lymphocyte-derived mediator. Science 1981 0.77
173 Adaptive differentiation of murine lymphocytes. IV (Responder x nonresponder) F1 T cells can be taught to preferentially help nonresponder, rather than responder, B cells. J Exp Med 1979 0.77
174 n-Docosanol 10% cream in the treatment of recurrent herpes labialis: a randomised, double-blind, placebo-controlled study. Acta Derm Venereol 1996 0.77
175 FcR epsilon+ lymphocytes and regulation of the IgE antibody system. III. Suppressive factor of allergy (SFA) is produced during the in vitro FcR epsilon expression cascade and displays corollary physiologic activity in vivo. J Immunol 1984 0.77
176 Prospects for the clinical control of IgE synthesis. Prog Clin Immunol 1980 0.76
177 Purification of murine suppressive factor of allergy into distinct CD23-modulating and IgE-suppressive proteins. Proc Natl Acad Sci U S A 1991 0.76
178 Immunologic tolerance to allergenic protein determinants: properties of tolerance induced in mice treated with conjugates of protein and a synthetic copolymer of D-glutamic acid and D-lysine (D-GL). J Immunol 1979 0.76
179 Hapten-specific IgE antibody responses in mice. VIII. A possible new mechanism by which anti-lymphocyte serum enhances IgE antibody synthesis in vivo. J Immunol 1977 0.76
180 The murine epsilon receptor modulating protein: a novel serine protease which modulates CD23 binding of IgE. Cell Immunol 1991 0.76
181 Cell-interaction molecules on immunocompetent lymphocytes. Development of anti-parent cell-interaction-molecule-receptor reactions in F1 hybrid mice and evidence for a unique F1 hybrid subset of interacting cells. J Exp Med 1981 0.75
182 Human rib bone marrow mononuclear cells spontaneously synthesize and secrete IgE in vitro. Clin Exp Immunol 1991 0.75
183 Role of B cell lymphokines in immunoregulation. Concepts Immunopathol 1986 0.75
184 Experimental dissection of an IgE class-selective regulatory cascade. Int Rev Immunol 1987 0.75
185 Monoclonal antibodies against vasoactive intestinal polypeptide: studies of structure and related antigens. J Neurochem 1983 0.75
186 The allogeneic effect in inbred mice. V. Analysis of B cell immunoglobulin classes influenced by non-specific and carrier-specific T cell stimuli. Cell Immunol 1976 0.75
187 Successful cooperative interactions between primed T and B lymphocytes derived from Gix+ and Gix- congenic mice. Cell Immunol 1978 0.75
188 The induction of murine B cell Ia by IgE-antigen complexes is dependent on protein synthesis and preceded by class II mRNA accumulation. Cell Immunol 1990 0.75
189 Elicitation of antigen-induced primary and secondary murine IgE antibody responses in vitro. Cell Immunol 1991 0.75
190 Identification of a T cell membrane protein possibly involved in IL-4-induced B cell immunoglobulin class switching to IgE. Cell Immunol 1994 0.75
191 B-cell-derived lymphokines: regulatory effects on the immune system. Crit Rev Immunol 1986 0.75
192 Use of a portable ribosome-binding site for maximizing expression of a eukaryotic gene in Escherichia coli. Gene 1986 0.75
193 B lymphocyte regulation of the immune system. II. Inhibition of Fc receptor expression of lymphocytes by BEF, a lymphokine of B cell origin. J Immunol 1985 0.75
194 Self-recognition, auto-immunity, and internal images. Curr Top Microbiol Immunol 1985 0.75
195 Characterization of murine interleukin B by a monoclonal antibody. Nature 1987 0.75
196 Augmentation of auto-anti-idiotypic antibody production by hapten-reactive helper T lymphocytes. Cell Immunol 1980 0.75
197 Fc epsilon RII and the activation of B lymphocytes. Monogr Allergy 1991 0.75
198 B cell sensitivity to IgE-suppressive activity of IFN-gamma is polymorphic and controlled by a non-H-2-linked gene. Cell Immunol 1992 0.75
199 Production of IL-1-mimicking anti-idiotypic antibodies in rabbits in response to IL-1 immunization. J Autoimmun 1988 0.75
200 Interactions between T and B lymphocytes in immune responses. J Invest Dermatol 1975 0.75
201 Cell interaction (CI) and anti-CI molecules: experiments and concepts on cell/cell interactions in the immune system. Ann Immunol (Paris) 1984 0.75
202 Non-allergenic haemolysins in grass pollens and housedust mites. Allergy 1983 0.75
203 Identification of a T cell hybridoma which produces extraordinary quantities of macrophage activating factor. Adv Exp Med Biol 1982 0.75
204 Promotion of hematopoietic stem cell differentiation in vitro by a soluble mediator, allogeneic effect factor. J Supramol Struct 1980 0.75
205 Haplotype preference in lymphocyte differentiation. II. F1 hybrid helper T cells generated with antigen-bearing parental macrophages can cooperate with B lymphocytes of either parent. Cell Immunol 1979 0.75
206 Spontaneous proliferation in unfractionated spleen cell cultures: autologous mixed-lymphocyte reactions (AMLR) which can be differentially regulated by prostaglandins and lymphokines. Cell Immunol 1984 0.75
207 Genetic controls and cellular interactions in antibody formation. Hosp Pract 1977 0.75
208 Allogeneic effect factor. Methods Enzymol 1985 0.75
209 Self-recognition as a means of cell communication in the immune system. Symp Soc Exp Biol 1978 0.75
210 Inhibitory activity of interleukin B on the suppressor T cell hybrid T2D4. J Immunol 1987 0.75
211 B cell activator. Effects on B cell expression of CD23, proliferation, and antibody secretion. J Immunol 1992 0.75
212 Induction of T lymphocyte responses to a small molecular weight antigen. I. Failure to induce tolerance in azobenzenearsonate (ABA)-specific T cells in guinea pigs with an ABA conjugate of A copolymer of D-glutamic acid and D-lysine (D-GL). J Immunol 1975 0.75
213 Hapten-specific IgE antibody responses in mice. IX. Suppression of IgE antibody production by passive transfer of T cells from adjuvant-primed syngeneic mice. J Immunol 1979 0.75
214 B-lymphocyte regulation of the immune system. III. Preparation and characterization of rabbit antibodies that inhibit the biological activity of the lymphokine, B-cell-derived enhancing factor (BEF). Cell Immunol 1986 0.75
215 A rapid, semi-automated counting procedure for enumeration of antibody-forming cells in gel and nucleated cells in suspension. J Immunol Methods 1977 0.75
216 Existence of T lymphocytes manifesting self-reactivity indistinguishable from alloreactivity: implications for self-recognition and MHC polymorphism. Transplant Proc 1981 0.75
217 Cloning of cDNA coding for low-affinity Fc receptors for IgE on human T lymphocytes. Int Immunol 1989 0.75
218 The allogeneic effect on tumor growth. II. Suppression of both ascitic and solid MOPC 315 plasmacytoma by the graft-vs-host reaction, with pathologic correlation. J Immunol 1977 0.75
219 Genetics of cell interactions in aged mice: age-related decline in capacity of parental cells or environment to induce allogeneic effects on F1 lymphocytes. J Immunol 1982 0.75
220 Perturbation of the autoimmune network. I. Immunization with anti-idiotypic antibodies prior to challenge with antigen induces quantitative variations in the autoantibody response. Autoimmunity 1988 0.75
221 The emerging importance of IgE and Fc receptors for IgE (Fc epsilon R) in the regulation of B cell activity. Contrib Microbiol Immunol 1989 0.75
222 Topical application of docosanol- or stearic acid-containing creams reduces severity of phenol burn wounds in mice. Contact Dermatitis 2000 0.75
223 'Allergic breakthrough': consequence of disturbance in normal 'damping' of IgE antibody production. Monogr Allergy 1979 0.75
224 B-cell lymphokines and activation of the immune system by internal structures. Immunol Today 1986 0.75
225 Plasticity of the immune response phenotype: evidence that responses against cell interaction molecules may determine the immune response phenotype in a given host environment. J Immunol 1981 0.75
226 Anti-TNP antibody responses in vitro: augmented primary responses of carrier-primed spleen cells. J Immunol 1971 0.75
227 The concept of adaptive differentiation: relevance to MHC polymorphism, self-recognition, and leukemogenesis. Transplant Proc 1980 0.75
228 New concepts concerning pathogenesis of the allergic phenotype and prospects for control of IgE antibody synthesis. Int Arch Allergy Appl Immunol 1981 0.75
229 Genetic control of cell-cell interactions in the immune system. Birth Defects Orig Artic Ser 1978 0.75
230 Genetic control of cell-cell interactions. Pharmacol Rev 1982 0.75